Glutamine, as an immunomodulatory nutrient and fuel for tumor cells, is transported by SLC1A5. In addition, the consequence of glutamine metabolism in cancer cells is the creation of a hypoxic, acidic, and nutrient-depleted tumor microenvironment (TME) (19, 57). Here, SLC1A5 is linked to neoplasm.